Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. The company offers INCB001158, an orally bioavailable arginase inhibitor of arginase that is in Phase 1/2 clinical trial for the treatment of hematology and oncology. It is developing CB-280, an oral arginase inhibitor that has completed Phase 1b clinical trial for the treatment of cystic fibrosis and chronic airway infection; and ATG-037, an orally-bioavailable small molecule inhibitor of CD73, as well as CB-668, an orally administered inhibitor of the enzyme IL4I1. The company has a license agreement with Mars, Inc. to develop and commercialize Symbioscience's portfolio of arginase inhibitors for use in human healthcare. It also has clinical trial collaboration with Pfizer to evaluate Pfizer's PARP inhibitor talazoparib and CDK4/6 inhibitor palbociclib, each in combination with telaglenasta. In addition, the company has a collaboration and license agreement with Incyte Corporation for the research, development, and commercialization of INCB001158, a small molecule arginase inhibitor for the treatment of hematology and oncology; and a license agreement with Antengene Corporation Ltd. for the development and commercialization of CB-708. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Calithera Biosciences Inc..
Calithera Biosciences Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Calithera Biosciences Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Calithera Biosciences Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Calithera Biosciences Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Calithera Biosciences Inc. and all latest updates of the company are provided.
The 2025 version of Calithera Biosciences Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Calithera Biosciences Inc.- Key Facts
2.2 Calithera Biosciences Inc.- Geographic Locations
2.3 Calithera Biosciences Inc.- Subsidiaries and Affiliates
2.4 Calithera Biosciences Inc.- Business Divisions
2.5 Calithera Biosciences Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Calithera Biosciences Inc. Strategic Analysis Review
3.1 Calithera Biosciences Inc.- Key Strategies
3.2 Calithera Biosciences Inc.- Company Outlook Statement
3.3 Calithera Biosciences Inc.- SWOT Analysis
3.3.1 Calithera Biosciences Inc.- Key Strengths
3.3.2 Calithera Biosciences Inc.- Key Weaknesses
3.3.3 Calithera Biosciences Inc.- Potential Opportunities
3.3.4 Calithera Biosciences Inc.- Potential Threats
3.4 Calithera Biosciences Inc.- Key Competitors
4. Business Description of the Company
4.1 Calithera Biosciences Inc.- Business Overview
4.2 Calithera Biosciences Inc.- Operations by Segment
5 Products and Services Details
5.1 Calithera Biosciences Inc.- Key Products
5.2 Calithera Biosciences Inc.- Key Service Areas
5.3 Calithera Biosciences Inc.- Key Brands
6 Company Developments
6.1 Calithera Biosciences Inc.- Company History
6.2 Calithera Biosciences Inc.- Latest Developments
7 Financial Analysis
7.1 Calithera Biosciences Inc.- Income Statements
7.2 Calithera Biosciences Inc.- Balance Sheet
7.3 Calithera Biosciences Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Calithera Biosciences Inc.- Direct Competitors
8.2 Calithera Biosciences Inc.- Competitor Financial Ratios comparison
8.3 Calithera Biosciences Inc.- Competitor Stock Charts Comparison
8.4 Calithera Biosciences Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!